Europe – Upcoming changes to REACH information requirements
The update of the REACH annexes clarifies the information companies need to submit in their registrations and makes ECHA’s evaluation practices more transparent and...
Europe – Group assessment of bisphenols identifies need for restriction
Many bisphenols are known endocrine disrupters both for human health and the environment. They also have reprotoxic properties. As they are widely used, a...
Europe – Pharmaceutical industry provides unpublished data on chemical substances
The datasets contain information about the hazard properties of 19 substances from 153 tests. The information can contribute to the development of predictive computational...
Europe – Projet of transfert du SCCS Sous la responsabilité de l’ECHA : COSMED...
Lancée en 2020, la stratégie chimique européenne , vise notamment à optimiser l’évaluation de la sécurité chimique des substances. Pour atteindre cet objectif une...
Europe – Natural and organic cosmetics: An overview of certification options
Interest in natural and organic cosmetics continues to rise amidst a wider green beauty boom, but with little regulation around these two terms, certification...
Europe – SCCS – Request for a scientific opinion on the hair dye ‘Sodium...
The ingredient with the INCI name ‘Sodium Bromothymol Blue’ and chemical name ‘Sodium α- (3-bromo-5-isopropyl-4-oxo-2-methyl-2,5-cyclohexadienylidene)-2-(3-bromo-4-hydroxy-5- isopropyl-2-methylphenyl)toluenesulphonate’ (CAS No. 34722-90-2, EC No. 252-169-7) is a...
Europe – SCCS – Final Opinion on Kojic acid
In light of the data provided and taking under consideration the concerns related to
potential endocrine disrupting properties of Kojic acid, does the SCCS consider...
Europe – Endocrine disruptors? SCCS closes comment period on phytoestrogens cosmetics safety
The European Commission’s Scientific Committee for Consumer Safety (SCCS) has closed the comment period for its preliminary safety opinion on the two phytoestrogen isoflavone...
Europe – SCCS : Request for a scientific opinion on Salicylic acid
On 7 November 2018, the Commission adopted the review1 of Regulation (EC) No 1223/2009 on cosmetic products (‘Cosmetics Regulation’) regarding substances with endocrine disrupting...
Europe – SCCS : OPINION on Prostaglandins and prostaglandin-analogues used in cosmetic products
In light of the data provided, does the SCCS consider Isopropyl cloprostenate (CAS
157283-66-4) and Ethyl Tafluprostamide or DDDE (CAS 1185851-52-8) safe when
used up to...
